Introduction {#Sec1}
============

Changes in the expression and post-translational modifications of myocardial proteins occur in the molecular background of myocardial remodeling during the development of chronic heart failure (HF). These alterations affect the myocardial structure and are responsible for disturbances in cellular functions ranging from intracellular signaling through cardiomyocyte contractility to metabolism. In this context, a number of studies have implicated the involvement of myofilamentary proteins in the progressive decay of the myocardial function \[[@CR12], [@CR30], [@CR33], [@CR42]\]. In the failing human heart, a downgraded β-adrenergic responsiveness was found to be associated with an increased Ca^2+^ sensitivity of force production through a diminished level of protein kinase A (PKA)-mediated troponin I (TnI) and myosin-binding protein-C (MyBP-C) phosphorylation \[[@CR6], [@CR27], [@CR41], [@CR43]--[@CR45]\], although these relationships were not fully confirmed in all models of HF \[[@CR4], [@CR5], [@CR28], [@CR37]\]. Some of the discrepancies arise from the complexity of the human pathology, the difficulty of finding reliable human control materials, and possible species-dependent differences between signaling pathways in large and small mammals \[[@CR26], [@CR35]\]. It follows that investigations in large animal models of HF are of great importance, as they will possibly elucidate HF-specific protein alterations with direct relevance for the human pathology.

A well-established large animal model of HF, induced by continuous cardiac pacing at a frequency three- to fourfold higher than the spontaneous heart rate, is mostly applied to dogs, pigs, sheep, and monkeys \[[@CR15], [@CR34]\]. One characteristic of this model is the presence of regional differences in functional and molecular remodeling. For example, in a canine tachy-pacing HF model, regional differences were noted in the extent of action potential prolongation and intracellular Ca^2+^ homeostasis abnormalities \[[@CR1]\]. Moreover, cardiac resynchronization therapy in these hearts furnished non-uniform responses \[[@CR2]\]. In a porcine model of HF, sustained pacing-induced dyssynchronous left ventricular (LV) activation caused more pronounced decreases in LV systolic thickening and circumferential shortening in the anterior/anterolateral region (pacing site) as compared with the inferoseptal region (opposite site) (to \~7 vs. \~31% and to \~−5 vs*.* \~−7%, respectively), which were unrelated to a uniform increase in glucose uptake in the corresponding regions \[further parameters of in vivo hemodynamic alterations of this model have been detailed in a previous study \[[@CR23]\] (p. H2750, Table [1](#Tab1){ref-type="table"})\]. However, these changes did correlate with an asymmetrical myocardial expression of natriuretic peptides \[[@CR10]\].Table 1Descriptive values for the distribution histograms of the flow cytometric experiments\[log(P-TnI/TnI)\] distributionControl pacing site (*n* = 6)Control opposite site (*n* = 6)HF pacing site (*n* = 6)HF opposite site (*n* = 6)25% percentile−*0.45*−*0.46*−*0.65*−*0.57*Median−*0.27*−*0.26*−*0.37*−*0.36*75% percentile−*0.09*−*0.09*−*0.12*−*0.15*IQR0.360.370.53^+,\#^0.42Mean−0.28−0.29−0.41\*−0.38Std. deviation*0.290.310.430.35*Std. error of mean*0.0020.0020.0030.002*Rows in italics were not analyzed statistically since these parameters cannot be interpreted at the single-particle level\* *P* = 0.0071 HF pacing versus control pacing site^+^*P* = 0.0093 HF pacing versus control pacing site^\#^*P* = 0.0047 HF pacing versus HF opposite site

In the present study, we set out to investigate a hypothetical relationship between PKA-dependent myofilament hypophosphorylation and the contractile dysfunction in a porcine model of pacing-induced HF. With a view to analyzing PKA-dependent TnI phosphorylation at the tissue and cellular levels, we performed biochemical studies (back-phosphorylation) in tissue homogenates, immunohistochemical studies in LV tissue slices, and flow cytometric assays in a large number of permeabilized cardiomyocytes isolated from paced and non-paced regions of failing LVs. To assess functional correlates, we measured the Ca^2+^ sensitivity of isometric force production (pCa~50~) and additional mechanical parameters of isolated cardiomyocytes of failing and healthy hearts.

Our data revealed disparate myocardial tissue characteristics within the LV of the HF animals and hence suggested a plausible explanation for the dyssynchronous LV activation.

Materials and methods {#Sec2}
=====================

Experimental tissue material {#Sec3}
----------------------------

Ten male, sexually mature minipigs (35--40 kg) were chronically instrumented in the laboratory of the Sector of Medicine, Scuola Superiore Sant'Anna, Pisa, Italy. HF was induced by pacing the LV anterior wall at 180 beats/min for 3 weeks. Pigs were considered to develop severe HF when the LV end-diastolic pressure was ≥20 mmHg and the ejection fraction was \<40%. Untreated animals were used as healthy controls. Hemodynamic measurements, MRI and PET examinations were performed in controls and in HF animals and identified regional wall motion abnormalities as reported earlier \[[@CR23]\]. The minipigs were then killed and their hearts were removed, dissected, and immediately frozen in liquid nitrogen. The anterolateral wall (pacing site) and inferoseptal region (opposite site) of the LVs were separated. Transfer of the cardiac samples between laboratories was performed on dry ice. The pigs were treated and housed in accordance with the Italian national guidelines (No. DLGS 27/01/1992, No. 116).

Immunohistochemistry {#Sec4}
--------------------

Porcine heart samples were sectioned in a cryostat at −20°C to obtain 10-μm-thick slices. All subsequent steps were performed at room temperature. Slides were fixed with ice-cold acetone for 5 min and incubated in methanol for 20 min. The fixed slides were then rinsed in PBS (containing 150.7 mM NaCl, 3.22 mM KCl, 0.735 mM KH~2~PO~4~, 8.6 mM Na~2~HPO~4~; pH 7.4) and blocked for 20 min in normal goat serum. A monoclonal mouse anti-TnI primary antibody (Clone 19C7, Research Diagnostics Inc., Flanders, USA; 1:500 dilution in PBS-BSA) was used to analyze TnI independently of its phosphorylation status, and a polyclonal rabbit anti-TnI (phospho S22 + S23) (Abcam, Cambridge, UK; 1:500 dilution in PBS-BSA) was employed to assess PKA-mediated TnI phosphorylation (P-TnI). Slides were incubated overnight at +4°C, followed by a 30-min incubation at room temperature with anti-mouse-Cy3 (red) and anti-rabbit-Cy2 (green) antibodies (Jackson Laboratories, Bar Harbor, ME, USA; 1:200 dilution in PBS) to visualize cardiac TnI and its PKA-specific phosphorylated form. To assess protein kinase C (PKC)-mediated TnI phosphorylation, polyclonal rabbit anti-TnI primary antibody (phospho T143) (Abcam, Cambridge, UK; 1:100 dilution in PBS-BSA) was used, followed by overnight incubation at +4°C, then 30 min incubation at room temperature with anti-rabbit-Biotin antibody (Jackson Laboratories, Bar Harbor, ME, USA; dilution: 1:200). Streptavidin-Cy2 (green) was used to visualize PKC-specific phosphorylation of TnI. Microscope slides were mounted with Vectashield mounting medium containing 4′,6-diamidino-2-phenylindole (DAPI) (Vector Laboratories, Burlingame, CA, USA). Microscopic images of tissue cuts were recorded with a NIKON Eclipse 80i Fluorescein microscope, using a NIKON 10× objective (NA:0.30) at 100× magnification. High-quality images were recorded with an Olympus FluoView 1000 Confocal microscope, using an Olympus LUCPLFLN 20× objective (NA:0.45) and digital zoom at 180× and 540× magnifications.

Back-phosphorylation of TnI {#Sec5}
---------------------------

A back-phosphorylation assay was performed to assess the phosphorylation level of TnI in protein homogenates of permeabilized cardiomyocytes \[[@CR11]\]. Permeabilized cardiomyocytes were prepared as described elsewhere \[[@CR8]\]. Reaction mixtures contained 40 μl of the isolated cardiomyocyte fraction {protein concentration 0.5 mg/ml in a modified isolation solution \[in mM: KCl 100, ethylene glycol tetraacetic acid (EGTA) 2, MgCl~2~ 1, ATP 0.1, and imidazole 100; pH 7.0; all chemicals from Sigma-Aldrich, St. Louis, MO, USA\]}, 10 μl of modified isolation solution containing ^32^P-labeled ATP (final specific activity: 1,500 cpm/pmol), and 1 μl of PKA \[from Sigma, St. Louis, MO, USA, 4,000 U/ml in 6 mg/ml of (dithiothreitol) DTT-containing modified isolation solution\]. The reaction was performed at room temperature for 15 min. At the end, 50 μl of sodium dodecyl sulfate (SDS) sample buffer (Sigma-Aldrich, St. Louis, MO, USA) was added and the samples were boiled for 5 min. Thirty microliters of boiled samples was loaded onto 10% polyacrylamide gels, separated, and transferred onto nitrocellulose membranes. Phosphate incorporation into TnI was detected by autoradiography (blue-sensitive RTGB films from Primax, Berlin, Germany). Band intensities (reflecting phosphate incorporation) were determined by densitometry using Image J software (freeware from <http://www.nih.gov>). Optical densities are shown in arbitrary units in the Figures.

Western immunoblotting {#Sec6}
----------------------

Porcine LV tissue samples were homogenized in radioimmune precipitation assay buffer containing Tris--Cl 50 mM, NaCl 150 mM, 1% Triton X-100, 0.1% SDS, and 1% sodiumdeoxycholate; pH 7.4. Protein concentrations were determined by BCA assay (Sigma-Aldrich, St. Louis, MO, USA) using bovine serum albumin (BSA) as standard, and the concentration of each homogenate was adjusted to 4 mg/ml. The homogenates were then mixed with an equal volume of 2× SDS sample buffer (Sigma-Aldrich, St. Louis, MO, USA) and were boiled for 10 min before electrophoresis. 50 μg of proteins was loaded onto 10% SDS-polyacrylamide gels and, after separation, transferred to nitrocellulose membranes. The membranes were probed with antibodies against TnI (Clone 19C7, Research Diagnostics Inc., Flanders, NJ, USA, dilution: 1:5,000) and the signal was detected with a peroxidase-conjugated anti-rabbit IgG-specific antibody (Sigma-Aldrich, St. Louis, MO, USA; dilution: 1:50,000). The bands were visualized by enhanced chemiluminescence and evaluated with Image J software. Only bands on the same membrane were used to avoid alterations due to differences in transfer efficiency or other technical reasons.

Flow cytometry {#Sec7}
--------------

LV tissue samples (\~0.04 g wet weight) were mechanically disrupted and isolated as described earlier. In brief, the isolated cells were permeabilized in cell isolation solution (in mM: MgCl~2~ 1, KCl 100, EGTA 2, ATP 4, and imidazole 10; pH 7.0; all chemicals from Sigma-Aldrich, St. Louis, MO, USA) as described elsewhere \[[@CR29]\]. Thereafter, the myocytes were incubated on ice for 90 min in 100 μl of isolation solution containing 2 mg/ml BSA (Sigma-Aldrich, St. Louis, MO, USA) and primary antibody. Monoclonal mouse anti-TnI antibody (Clone 19C7, Research Diagnostics Inc., Flanders, NJ, USA; dilution: 1:200), and a phosphorylation-sensitive polyclonal rabbit anti-TnI antibody (phospho S22 + S23) (Abcam, Cambridge, UK; 1:100 dilution) were used as primary antibodies, followed by a 30-min incubation on ice with anti-mouse-Cy3 and anti-rabbit-Cy5 antibodies (Jackson Laboratories, Bar Harbor, ME, USA; dilution: 1:50) to label cardiac TnI and P-TnI. Myocytes were fixed with ice-cold 2% formaldehyde solution (in cell isolation solution) for 30 min. All washing steps were performed with isolation solution. The cell suspensions were gently sonicated and then filtered through a 50-μm-wide cell filter. Flow cytometric experiments were carried out on a FACSArray flow cytometer (Becton--Dickinson, San Jose, CA, USA). Fluorescence intensities for single particles were determined in six animals per group. 6,000--10,000 particles were measured per animal. Cy3 fluorescence was excited at 532 nm and detected at 585 ± 21 nm, whereas Cy5 was excited at 635 nm and detected at 661 ± 8 nm. Cell debris was excluded from the analysis by gating on the forward and right angle light scatter signals. List mode files were analyzed with the software REFLEX \[[@CR39]\].

Force measurements in permeabilized cardiomyocyte preparations {#Sec8}
--------------------------------------------------------------

The force at saturating \[Ca^2+^\] (*F*~o~), the passive force component (*F*~passive~), the Ca^2+^ sensitivity of isometric force production (pCa~50~), the steepness of the Ca^2+^--force relationship (*n*~Hill~), and the rate constant of force redevelopment at saturating Ca^2+^ levels (*k*~tr,max~; specific for the maximal turnover rate of the actin-myosin cross-bridge cycle) were used as parameters of the myofibrillar function. Moreover, these mechanical data were determined at sarcomere lengths (SLs) of 1.9 and 2.3 μm to test for possible alterations in length-dependent Ca^2+^ sensitization, i.e. in the molecular background of the Frank-Starling mechanism. The pCa, i.e. −log\[Ca^2+^\], values of the relaxing solution and the activating solution used during the force measurements (pH 7.2) were 9.0 and 4.75, respectively. The composition of the relaxing solution differed from that of the activating solution only in the use of 7 mM EGTA instead of Ca-EGTA. Both solutions were supplemented with protease inhibitors: 0.5 mM phenylmethylsulfonyl fluoride (PMSF) (Sigma-Aldrich, St. Louis, MO, USA), 40 μM leupeptin (Sigma-Aldrich, St. Louis, MO, USA), and 10 μM E-64 (Sigma-Aldrich, St. Louis, MO, USA).

The technique employed for force measurements in a single myocyte-sized preparation was detailed earlier \[[@CR29]\]. Briefly, a single permeabilized cardiomyocyte was attached to a mechanical measuring system. After precise SL adjustment to 2.3 μm, isometric Ca^2+^ contractures were evoked at 15°C during repeated activation--relaxation cycles by moving the myocyte from Ca^2+^-free relaxing solution to activating solutions of gradually increasing \[Ca^2+^\]. Isometric force values were normalized for maximal Ca^2+^-activated active force, and Ca^2+^--force relations were plotted and fitted with a modified Hill function to determine the Ca^2+^ sensitivity of isometric force production, i.e. pCa~50~, and the cooperativity within the contractile machinery (*n*~Hill~). Ca^2+^--force relationships were determined before and after in vitro PKA exposures. The PKA stock solution contained the catalytic subunit of PKA from bovine heart \[100 U in distilled water supplemented with 6 mg/ml of DTT at a protein concentration of 0.05 mg/ml, as recommended by the manufacturer (Sigma-Aldrich, St. Louis, MO, USA; Catalog number: P2645; LOT number: 021M7676V)\]. To assess the effects of PKA, cardiomyocytes were incubated for 20 min in 100 μl of relaxing solution supplemented with 5 μl of the PKA stock solution. In a separate study, isometric force measurements were performed first at a SL of 1.9 μm and then at a SL of 2.3 μm.

During single Ca^2+^ contractures, once the peak force was reached, the rate constant of force redevelopment (*k*~tr,max~) was determined by a quick release--restretch maneuver in the activating solution. As a result of this intervention, the force dropped from peak level to zero, allowing determination of the total force level (*F*~total~), and then started to redevelop. The cardiomyocyte was next returned to the relaxing solution, where a shortening to 80% of the original preparation length was performed to assess the passive force level (*F*~passive~). The active isometric force (*F*~o~) was calculated by subtracting the passive force from the total isometric force. *F*~o~ and *F*~passive~ were normalized for the cardiomyocyte cross-sectional area, calculated from the width and thickness of the myocyte, which were measured with optically directed light.

Data analysis, statistics {#Sec9}
-------------------------

Ca^2+^--force relations were fitted to a modified Hill equation:$$\documentclass[12pt]{minimal}
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The force redevelopment after the release--restretch maneuver was fitted to a single exponential function in order to estimate the rate constant of force redevelopment (*k*~tr,max~) at the maximal \[Ca^2+^\] level:$$\documentclass[12pt]{minimal}
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\end{document}$$where *F*(*t*) is the force at any time (*t*) after the restretch at the maximal \[Ca^2+^\], and *F*~i~ and *F*~a~ denote the initial force after the restretch and the amplitude of Ca^2+^-activated force redevelopment, respectively. Each experimental preparation was fitted individually, the fitted parameters were pooled, and the mean values are reported.

Statistical analyses of the back-phosphorylation assay and mechanical measurements were performed by ANOVA followed by a Bonferroni test for multiple comparisons between groups. Relationships between two continuous variables were assessed with linear regression analysis. Differences due to PKA treatment during mechanical measurements were analyzed using a paired Student's *t* test. Statistical significance was accepted at *P* \< 0.05. Analysis of the thousands of single data points obtained from the flow cytometric measurements required a modeling method that does not assume independence across single particles, but is able to handle the correlation between particle-level measurements within the same animal's heart. Thus, conventional ANOVA or linear regression could not be used, but maximum likelihood mixed effects multilevel modeling with interaction between groups and sites was found to be appropriate. Estimation of the pacing effect was based on mean log relative signal intensities \[log(P-TnI/TnI)\] for the level of phosphorylation and on interquartile ranges (IQRs) for the heterogeneity of phosphorylation. Logarithmic transformation of the data improved the normality of the distribution of the variables.

Results {#Sec10}
=======

To test homogeneity in PKA-mediated myofilament protein phosphorylation, the level of TnI phosphorylation was visualized during immunohistochemical studies on myocardial tissue samples in the anterior/anterolateral (pacing site) and in the inferoseptal regions (opposite site) in HF and control hearts. Myocardial tissue samples were labeled with specific antibodies against TnI, the phosphorylated form of TnI (P-TnI) at PKA-specific sites (S22 + S23), and slides were also mounted with DAPI-containing medium. In Fig. [1](#Fig1){ref-type="fig"}, beside the three separate signals captured with fluorescent light microscopy, merged pictures from each group are also shown. In general, the staining of tissue slices for P-TnI resulted in a more homogeneous staining intensity in the controls and opposite site of HF hearts than in the pacing site of HF hearts, where areas with various P-TnI intensity levels could be observed. Areas with given staining intensities were formed by clusters of cardiomyocytes with similar P-TnI signal levels in the pacing site of HF hearts (Fig. [1](#Fig1){ref-type="fig"}b). The P-TnI staining did not appear to vary within single cardiomyocytes. The homogenous picture with phosphorylation-insensitive TnI antibody and the identification of cardiomyocyte nuclei by DAPI were in contrast with the inhomogeneous pattern observed following P-TnI staining in the same myocardial sections, and hence indicated that fibrosis or necrosis could not explain the heterogeneous staining pattern at the pacing sites of HF hearts. In a separate study, we also attempted to test the homogeneity of PKC-mediated TnI phosphorylation at the pacing site of HF animals. To this end, myocardial tissue samples were labeled similarly as those in Fig. [1](#Fig1){ref-type="fig"} for the PKA-specific TnI phosphorylation sites and also with antibodies specific for a PKC-specific TnI phosphorylation site (T143) (Online Resource 1). In general, these sections suggested TnI phosphorylation to be more homogenous at the PKC site than at the PKA-specific sites.Fig. 1Immunohistochemistry. **a** Myocardial tissue samples were labeled with specific antibodies against TnI, the phosphorylated form of TnI (P-TnI) and nuclei with DAPI. Disparate amounts of P-TnI intensities resulted in variable yellow intensities on the merged picture of the HF pacing group. **b** Capturing images of P-TnI stained slices under a confocal microscope revealed cell-to-cell differences: clusters of cardiomyocytes with divergent levels of TnI phosphorylation could be distinguished in the HF animals at the pacing site

The mean levels of myofilament protein phosphorylation were tested in a back-phosphorylation assay. The mean phospho-specific TnI signal intensity of protein homogenates of permeabilized cardiomyocytes from the pacing sites of the HF animals (58 ± 14.49 AU) was significantly higher than that in the control pigs (5.41 ± 1.34 AU; *P* \< 0.05), which was suggestive of a PKA-dependent phosphorylation deficit of TnI at the HF pacing site (Fig. [2](#Fig2){ref-type="fig"}a, b). The phosphorylation-dependent intensities at the molecular masses of 20 and 150 kDa \[i.e. close to those of MyBP-C and myosin light chain 2 (MLC2)\] correlated with TnI phosphorylation (Fig. [2](#Fig2){ref-type="fig"}c). Parallel changes in TnI phosphorylation and MyBP-C phosphorylation are expected upon PKA applications; however, phosphate incorporation into MLC2 is not expected for PKA exposures, and hence the protein at 20 kDa could be a protein other than MLC2. The difference in the overall phosphorylation level of myocardial TnI (P-TnI) between the pacing and the opposite sites of the HF pigs did not reach significance (*P* \> 0.05) (HF opposite site: 40.3 ± 9.86 AU) (Fig. [2](#Fig2){ref-type="fig"}a, b).Fig. 2TnI back-phosphorylation. **a** Results of autoradiography (*top*) and western immunoblotting (*bottom*) in a representative TnI back-phosphorylation assay. ^32^P-labeled ATP was used to determine PKA-dependent phosphate incorporation into TnI at the pacing and opposite LV sites in control and HF animals following SDS gel electrophoresis. Signal intensities in the autoradiograms were considered to be directly proportional to the extents of inorganic phosphate (P~i~) incorporation into TnI in the presence of PKA (+ signs) in vitro*,* and inversely proportional to the initial levels of phosphorylation of TnI prior to PKA application in vivo. Signal intensities in the absence of PKA were negligible (− signs). Western immunoblots developed with a TnI-sensitive antibody confirmed comparable protein loads during all tests. **b** Statistical analysis on the results of back-phosphorylation assays under identical conditions suggested a lower mean level of TnI phosphorylation for the HF pacing site than for the control pacing site (columns show means ± SEM; *n* number of animals, AU optical density in arbitrary units, \**P* \< 0.05 HF pacing vs*.* control pacing site). **c** Correlations between TnI phosphorylation and additional proteins at 20 and 150 kDa. Signal intensities at 20 and 150 kDa from pacing and opposite sites of individual animals were plotted in an *X--Y* diagram as functions of P~i~ incorporation into TnI in the respective samples. *Lines* represent relationships between phosphorylation at 20 or 150 kDa and TnI phosphorylation from linear regression analyses, suggesting positive correlations between these variables (*r* = 0.71, *P* \< 0.0001; *r* = 0.74, *P* \< 0.0001, respectively)

Motivated by the results of our histochemical observations and back-phosphorylation assays, we developed a protocol that allowed the quantitative evaluation of regional differences in the level of TnI phosphorylation in suspensions of permeabilized cardiomyocytes by flow cytometry. This method yielded relative P-TnI levels in a vast number of cardiomyocytes following dual-labeling of cardiomyocytes for TnI and P-TnI (Fig. [3](#Fig3){ref-type="fig"}a). Distribution histograms of logarithmically transformed relative signal intensities \[log(P-TnI/TnI)\] were then expressed for the two regions of interest in the HF and control groups by pooling data from six hearts in each group. Figure [3](#Fig3){ref-type="fig"}b shows that the distribution histogram of the pacing site in the controls demonstrated close to Gaussian distribution, in contrast with the histogram of the HF pacing site, which appeared to be asymmetrical due to an increase in cardiomyocyte count at relatively low \[log(P-TnI/TnI)\] ratios. In agreement with the results of our back-phosphorylation assays (Fig. [2](#Fig2){ref-type="fig"}a, b), the mean value of \[log(P-TnI/TnI)\] at the HF pacing site was significantly lower than that at the same site in the control animals (−0.41 vs. −0.28 for the HF pacing site and the control pacing site, respectively; *P* = 0.0071), and hence both of these assays pointed to a relative reduction in P-TnI in the paced region of failing hearts. Moreover, the IQR in this group was significantly higher than that at the pacing site of the controls or at the opposite site of failing hearts (0.53 vs. 0.36 or 0.42, for the HF pacing, control pacing and HF opposite sites, respectively; *P* = 0.0093 vs. control pacing site; *P* = 0.0047 vs*.* HF opposite site). The widening of the IQR at the HF pacing site reflected the increased scatter in the levels of relative TnI phosphorylation at the pacing site among the cardiomyocytes of failing hearts. Descriptive values of distribution histograms are given in Table [1](#Tab1){ref-type="table"}.Fig. 3Flow cytometry. **a** Microscopic images of a representative permeabilized cardiomyocyte (*top panel*) dual-labeled for TnI (*red*) and P-TnI (*green*) for flow cytometric evaluation. Signal intensities were plotted in *X--Y* diagrams, where the values on the *X* and *Y* axes reflected TnI and P-TnI intensity levels, respectively (*middle* and *lower panels*, *n* ≈ 20,000 cardiomyocytes from 6 hearts). The wider scatter of the data obtained from the HF pacing site (*bottom panel*) than those from the control pacing site (*middle panel*) suggested more heterogeneous TnI phosphorylation levels in the cardiomyocytes of the HF animals in the paced area. **b** Distribution of relative TnI phosphorylation in isolated cardiomyocytes. Distribution profiles of logarithmically transformed relative signal intensities \[log(P-TnI/TnI)\] were expressed for the four groups. (The IQRs between the 25 and 75 percentile values of the distribution histograms are highlighted; *n* number of animals; \**P* = 0.0071 HF pacing vs*.* control pacing site; ^+^*P* = 0.0093 HF pacing vs. control pacing site; ^\#^*P* = 0.0047 HF pacing vs. HF opposite site)

Mean levels of log(P-TnI/TnI) intensities with 95% confidence intervals for each animal are illustrated in Fig. [4](#Fig4){ref-type="fig"}. This representation allowed us to analyze the variability of TnI phosphorylation in the different regions of interest in the individual control and failing hearts. In general, the log(P-TnI/TnI) values for the control hearts were scattered in a narrower range than those for the failing hearts. Further, in the control animals the means of log(P-TnI/TnI) were randomly higher or lower for the pacing or opposite sites, and the differences between these two sites (with the exception of control 4) were small. In contrast, in HF (with the exception of HF 6) the means for the log(P-TnI/TnI) values at the pacing sites were lower than those at the opposite sites. Moreover, the differences between the two sites of individual failing hearts were about twice the mean difference detected within the control group.Fig. 4TnI phosphorylation in experimental animals. Mean levels of \[log(P-TnI/TnI)\] intensities with 95% confidence intervals for each site of each animal. *Horizontal lines* indicate average \[log(P-TnI/TnI)\] values of control and HF pacing sites. The \[log(P-TnI/TnI)\] values for the control animals were scattered in a narrower range than those for the HF animals

A hypothetical difference in cardiomyocyte mechanics was also studied by means of direct force measurements on single permeabilized cardiomyocytes isolated from HF and control animals (Fig. [5](#Fig5){ref-type="fig"}). Ca^2+^ sensitivity curves of isometric force production (Ca^2+^--force relations) were determined for individual cardiomyocytes and subsequently averaged in all groups at 2.3 μm SL before and after PKA exposures (Fig. [5](#Fig5){ref-type="fig"}a--d). Force values at intermediate \[Ca^2+^\] were normalized to maximal Ca^2+^-activated force (*F*~o~) and plotted as a function of pCa. A Hill function was then used to determine pCa~50~, which therefore illustrated the Ca^2+^ sensitivity of force production. Mean pCa~50~ values of control hearts at the pacing site did not differ significantly from those of the opposite site in control and HF hearts before PKA treatments (5.77 ± 0.01, 5.75 ± 0.01 and 5.73 ± 0.03, respectively). However, mean pCa~50~ (and hence Ca^2+^ sensitivity of force production) was significantly higher at the pacing site of HF hearts (5.86 ± 0.03) than at all the other sites of HF and control hearts. Moreover, PKA exposures reduced pCa~50~ by the largest degree in cardiomyocytes of the pacing site of HF animals, thereby eliminating the differences in the Ca^2+^ sensitivities of force production among the four groups of cardiomyocytes. In addition, the distributions of pCa~50~ at the pacing sites of the failing and the control hearts resembled the characteristics of those obtained in our flow cytometric assays and were therefore also in agreement with the biochemical and histochemical findings (Fig. [5](#Fig5){ref-type="fig"}e--h). Furthermore, in vitro PKA treatments evoked a wider range in Ca^2+^ sensitivity reductions at the HF pacing site than at all other sites. Mean values of *F*~o~, *F*~passive~ and the cross-bridge-sensitive *k*~tr,max~ are given in Table [2](#Tab2){ref-type="table"}. *F*~passive~ at the HF pacing site was significantly higher than at the HF opposite site; however, no significant differences in *F*~o~ and in maximal actin-myosin cross-bridge cycle rates (*k*~tr,max~) were found between the different experimental groups.Fig. 5Mean Ca^2+^--force relations and distributions of pCa~50~ values in isolated cardiomyocytes. **a** Ca^2+^--force relations of isolated cardiomyocytes obtained from the pacing and opposite sites of the HF animals before and after in vitro PKA treatments. The leftward position of the Ca^2+^--force relations at the HF pacing site before PKA treatment illustrated an increased Ca^2+^-sensitivity of force production in cardiomyocytes of this region relative to all others. After PKA treatment, a rightward shift in the Ca^2+^--force relation was observed. **b** Small differences between the Ca^2+^--force relationships of the control pacing and control opposite groups could be detected before and after in vitro PKA treatment. **c** Means of pCa~50~ values in the four groups of cardiomyocytes before and after in vitro PKA treatment. Mean pCa~50~ at the HF pacing site was significantly higher than in all other groups under basal conditions, and this difference could be eliminated by PKA (\**P* \< 0.05). **d** PKA-evoked changes in pCa~50~ values in the four experimental groups. The effect of PKA on mean pCa~50~ was the highest at the pacing site of HF animals (\**P* \< 0.05). The Hill coefficient did not differ significantly among the four experimental groups before and after PKA exposures (*n*~Hill~ \~2.6). **e**--**h** Distributions of pCa~50~ values in cardiomyocytes from the four experimental groups before and after in vitro PKA treatment. pCa~50~ values of the HF pacing group were dispersed on a wider range than in all other groups. After PKA treatment, a narrower distribution for the pCa~50~ values could be measured in HF cardiomyocytes at the pacing siteTable 2Mean values of active, passive force and *k*~tr,max~ obtained during direct force measurements in permeabilized cardiomyocytesControl pacing site (*n* = 23)Control opposite site (*n* = 20)HF pacing site (*n* = 21)HF opposite site (*n* = 29)*F*~o~ (kN/m^2^)12.83 ± 1.7315.47 ± 1.8412.05 ± 1.1516.81 ± 1.42*F*~passive~ (kN/m^2^)1.46 ± 0.201.69 ± 0.432.26 ± 0.48^\*^1.17 ± 0.11*k*~tr,max~ (1/s)0.81 ± 0.060.75 ± 0.040.82 ± 0.050.96 ± 0.05Values are means ± SEM*n* number of cardiomyocytes from 5 control and 8 HF hearts\* *P* \< 0.05 HF pacing versus HF opposite site

In a separate study, the length dependencies of the mechanical parameters were investigated by performing force measurements at the SL of 1.9 μm and subsequently at the SL of 2.3 μm. In short, length dependencies of *F*~o~, *F*~passive~, and the Ca^2+^ sensitivity of force production were observed in all groups of cardiomyocytes, implying that the stretch-dependent mechanical characteristics of the cardiomyocytes are well preserved during the development of pacing-induced HF (data not shown).

Discussion {#Sec11}
==========

The results of this study have revealed a non-uniform down-regulation of myocardial PKA-dependent TnI phosphorylation in a porcine model of pacing-induced HF. Interestingly, the cell-to-cell variability in the level of P-TnI was larger in the vicinity of the pacing electrode than in non-paced regions of the LV. Consequently, we propose that the inhomogeneity in PKA-dependent contractile protein hypophosphorylation may contribute to the regional mechanical dysfunction of the remodeled myocardium in this model of HF.

Dyssynchrony in ventricular contractile responses is considered to be a major contributor of the mechanical dysfunction in the remodeled LV, and hence electrical resynchronization offers benefit for HF patients with a significant QRS prolongation \[[@CR32]\]. Regional myocardial differences have repeatedly been noted in various models of HF induced by electrical stimulation \[[@CR10], [@CR14], [@CR23], [@CR25], [@CR38]\]. In open-chest anesthetized dogs, abnormal wall motion at the target site of the LV yielded early shortening and late systolic lengthening, whereas the shortening pattern at the remote site remained unaffected \[[@CR14]\]. Various mechanisms have been postulated to explain these region-specific changes, ranging from matrix metalloproteinase-9 activation \[[@CR14]\] to transmural and trans-chamber expression gradients of proteins such as phosphorylated ERK mitogen-activated protein kinase, sarcoplasmic reticulum Ca^2+^-ATPase, phospholamban, or gap junction protein connexin 43 \[[@CR20], [@CR38]\]. Paracrine/autocrine signaling mechanisms have also been stressed as players in the development of regional tissue alterations in pacing-induced HF. For instance, the cardiotropin-1 expression was found to be preferably increased in the vicinity of the pacemaker \[[@CR31]\]. In a canine model of pacing-induced HF, an orchestrated shift in the pattern of expression of respiratory chain subunits, mitochondrial bioenergetic enzymes, and apoptotic proteins with distinct differences in the regional distribution and in the subpopulations of mitochondria have been described \[[@CR25]\]. Collectively, it is currently not entirely clear which signaling processes are primarily involved in regional mechanical alterations and how they are linked with potential changes in the Ca^2+^ responsiveness of the myofilaments and/or with the Ca^2+^ handling of cardiomyocytes \[[@CR1], [@CR2], [@CR17]\]. Nevertheless, it is tempting to speculate that paracrine responses to natriuretic peptides may relate to interactions between cGMP and cAMP-dependent intracellular signaling \[[@CR13]\].

In view of the central position of the β-adrenergic cascade in the regulation of myocardial contractility, several previous investigations addressed its hypothetical involvement in the regional characteristics of pacing-induced HF. Indeed, the efferent sympathetic function and β-adrenergic responsiveness appeared to be reduced in association with the development of pacing-induced HF in dogs with region-specific alterations in function \[[@CR19], [@CR36]\], although the biochemical and cellular parameters of β-adrenergic signaling did not clearly exhibit regional characteristics \[[@CR3], [@CR18], [@CR36], [@CR40]\]. At the cardiomyocyte level, a decrease in basal β-adrenergic signaling would predict an increase in the Ca^2+^ sensitivity of myofibrillar force production, a change often correlated with the coordinated hypophosphorylation of TnI and MyBP-C \[[@CR21], [@CR24], [@CR43]\]. Experimental data obtained during an in situ assessment of myofilament Ca^2+^ responsiveness suggested either preserved or decreased Ca^2+^ sensitivity of myofibrillar force production in a canine model of pacing-induced HF \[[@CR16]\]. Moreover, in the porcine model of pacing-induced HF, the relative increase in LV contractility in response to low-dose dobutamine stimulation was higher at the pacing site than at the opposite site, although the basal contractility was lower at the pacing site than at the opposite site \[[@CR22]\].

In our present study, we focused not only on regional, but also on intraregional aspects of a hypothetically blunted PKA-mediated TnI phosphorylation, along with the development of pacing-induced HF in pigs. We hypothesized that tissue-level alterations in TnI phosphorylation driven by the β-adrenergic system might be associated with regional differences in the mechanical function of the remodeled myocardium. Our back-phosphorylation assays revealed significantly decreased TnI phosphorylation at the pacing site of the HF animals as compared with the controls, consistently with a hypothetical down-regulation of the β-adrenergic system at the pacing site of the HF animals and hence implying an increase in the Ca^2+^ sensitivity of myofibrillar force production (pCa~50~). Accordingly, the mean pCa~50~ values were significantly higher at the HF pacing site than at the opposite site or both sides in controls, and this difference could be eliminated by in vitro PKA treatments. In addition, immunohistochemistry, flow cytometry, and direct force measurements confirmed a relatively high cell-to-cell variability in the relative P-TnI levels at the pacing site of the HF animals. The preservation of most of the mechanical parameters in the cardiomyocytes of the paced region of the HF animals (e.g. the SL dependence of the Ca^2+^ sensitivity of force production, *k*~tr,max~, etc.) suggested an unchanged Frank-Starling mechanism and cross-bridge cycling rates in these cardiomyocytes. Overall, our observations suggested that alterations in the myofilament function of the cardiomyocytes were mirrored by pCa~50~ at the pacing site of the HF animals, a change that can be correlated to PKA-dependent TnI and MyBP-C phosphorylation. Therefore, we propose that dysregulation of PKA-dependent contractile protein phosphorylation may contribute to the regional contractile dysfunction observed in the porcine model of pacing-induced HF \[[@CR23]\]. Additionally, the increase in *F*~passive~ at the pacing site due to PKA-dependent hypophosphorylation of other myofilament proteins (e.g. titin) could participate in the increase in LV end-diastolic pressure in these hearts (from \~6 to \~ 20 mmHg) \[[@CR7]\]. Nevertheless, our present investigations did not clarify to which extent regional alterations in myofilament protein phosphorylation were involved in functional hemodynamic alterations (e.g. reduction in the ejection fraction from \~76 to \~35%) \[[@CR23]\].

To the best of our knowledge, this is the first analysis of tissue-level inhomogeneities in cardiomyocyte TnI phosphorylation through a combination of a number of sensitive methods (protein biochemistry, histochemistry, direct force measurements and cell cytometry) during the development of non-ischemic HF. A diminishing transmural gradient in contractile protein phosphorylation has previously been implicated in post-ischemic myocardial remodeling in rats \[[@CR9]\], although similar features have not been demonstrated in dogs suffering from pacing-induced HF \[[@CR20]\]. Our data revealed that the level of TnI phosphorylation spans a wider range in the vicinity of the pacing electrode than elsewhere and suggested that it can be distinctly different in clusters of cardiomyocytes during pacing-induced HF. At present, we cannot provide an explanation for this distribution pattern of P-TnI staining intensity; we speculate that it may be related to the physical characteristics of the stimulating electrical current on the myocardium.

Overall, the rapid pacing of the LV induced the remodeling of porcine hearts and led to HF, which could be characterized by an overall decrease in PKA-mediated TnI phosphorylation close to the site of electrical stimulation. The level of PKA-dependent phosphorylation of TnI exhibited a larger cell-to-cell variation in the paced region of the LV than in more remote areas or in controls. This intraregional inhomogeneity in this β-adrenergic-dependent variable affects the Ca^2+^ sensitivity of myofibrillar force production and may thereby contribute to dyssynchronous and hence impaired LV contractions in the porcine model of pacing-induced HF.
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